Ambien, Sonata, and Lunesta get stronger warning from FDA
"Serious consequences of taking the medicines are said to be rare. But they occur often enough that last week, the U.S. Food and Drug Administration increased its level of caution for several of the so-called Z-drugs, requiring them to be labeled with ”boxed" warnings. We spoke with Karl Doghramji, medical director of the Jefferson Sleep Disorders Center, about what it means."
Recommended CitationAvril, Tom, "Ambien, Sonata, and Lunesta get stronger warning from FDA" (2019). Jefferson Sleep Disorders Center in the News. Paper 12.